Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Thumbnail

Long-term anticoagulation a safe treatment option for elderly AFib patients

Long-term anticoagulation can be recommended for AFib patients 90 years old and older, according to new research. 

Thumbnail

Risk of death, disability after stroke much higher for COVID-19 patients

Experiencing a stroke while your body is already battling COVID-19 can be especially dangerous, this new study suggests. 

Cardiologists detail why blood clots are so common among COVID-19 patients

"In patients with COVID-19, we continue to see a relentless, self-amplifying cycle of inflammation and clotting in the body," one researcher said. 

Boston Scientific gains FDA approval for Ranger drug-coated balloon

The newly approved solution was designed for the treatment of patients with PAD in the superficial femoral artery and proximal popliteal artery.

American Heart Association, Society of Vascular and Interventional Neurology launch online-only journal

The journal is expected to begin publishing by early 2021.

Medtronic’s new stent system for deep venous obstruction gains FDA approval

The approval comes after Medtronic reported the successful results of a clinical study focused on 200 patients.

4 key ways to fight back and reduce the risk of stroke

World Stroke Day is on the horizon, and the American Stroke Association is highlighting the potential power of prevention. 

Thumbnail

Daily aspirin improves outcomes for hospitalized COVID-19 patients

“If our finding is confirmed, it would make aspirin the first widely available, over-the-counter medication to reduce mortality in COVID-19 patients," one researcher observed. 

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.